https://www.alnylam.com/ en https://www.alnylam.com/node/13566 <span>FDA accepts Alnylam’s siRELIS TM enzymatic ligation manufacturing platform into its Emerging Technology Program, fast-tracking global regulatory engagement</span> <span><span lang="" about="/user/220" typeof="schema:Person" property="schema:name" datatype="">hmotawe</span></span> <span>Wed, 12/17/2025 - 20:35</span> <div class="field field--name-field-year field--type-string field--label-hidden field--item">2025</div> <div class="field field--name-field-timeline-color field--type-string field--label-hidden field--item">#fff</div> <div class="field field--name-field-timeline-description field--type-text-long field--label-hidden field--item"><p>FDA accepts Alnylam’s siRELIS^TM enzymatic ligation manufacturing platform into its Emerging Technology Program, fast-tracking global regulatory engagement</p> </div> <div class="field field--name-field-list-integer field--type-integer field--label-hidden field--item">4</div> <div class="field field--name-field-link field--type-string field--label-hidden field--item">https://investors.alnylam.com/press-release?id=29466</div> <div class="field field--name-field-in-manufacturing field--type-boolean field--label-hidden field--item">On</div> Wed, 17 Dec 2025 20:35:38 +0000 hmotawe 13566 at https://www.alnylam.com https://www.alnylam.com/node/13567 <span>$250M expansion of Norton, MA (USA) manufacturing facility announced; expansion will add enzymatic&amp;nbsp;ligation manufacturing capability to meet growing demand for RNAi therapeutics</span> <span><span lang="" about="/user/220" typeof="schema:Person" property="schema:name" datatype="">hmotawe</span></span> <span>Wed, 12/17/2025 - 20:35</span> <div class="field field--name-field-year field--type-string field--label-hidden field--item">2025</div> <div class="field field--name-field-timeline-color field--type-string field--label-hidden field--item">#fff</div> <div class="field field--name-field-timeline-description field--type-text-long field--label-hidden field--item"><p>$250M expansion of Norton, MA (USA) manufacturing facility announced; expansion will add enzymatic ligation manufacturing capability to meet growing demand for RNAi therapeutics</p> </div> <div class="field field--name-field-list-integer field--type-integer field--label-hidden field--item">5</div> <div class="field field--name-field-link field--type-string field--label-hidden field--item">https://investors.alnylam.com/press-release?id=29466</div> <div class="field field--name-field-in-manufacturing field--type-boolean field--label-hidden field--item">On</div> Wed, 17 Dec 2025 20:35:37 +0000 hmotawe 13567 at https://www.alnylam.com https://www.alnylam.com/node/13565 <span>$250M expansion of Norton, MA (USA) manufacturing facility announced; expansion will add enzymatic&amp;nbsp;ligation manufacturing capability to meet growing demand for RNAi therapeutics</span> <span><span lang="" about="/user/220" typeof="schema:Person" property="schema:name" datatype="">hmotawe</span></span> <span>Wed, 12/17/2025 - 20:30</span> <div class="field field--name-field-year field--type-string field--label-hidden field--item">2025</div> <div class="field field--name-field-timeline-color field--type-string field--label-hidden field--item">#fff</div> <div class="field field--name-field-timeline-description field--type-text-long field--label-hidden field--item"><p>$250M expansion of Norton, MA (USA) manufacturing facility announced; expansion will add enzymatic ligation manufacturing capability to meet growing demand for RNAi therapeutics</p> </div> <div class="field field--name-field-list-integer field--type-integer field--label-hidden field--item">5</div> <div class="field field--name-field-link field--type-string field--label-hidden field--item">https://investors.alnylam.com/press-release?id=29466</div> <div class="field field--name-field-in-manufacturing field--type-boolean field--label-hidden field--item">Off</div> Wed, 17 Dec 2025 20:30:23 +0000 hmotawe 13565 at https://www.alnylam.com https://www.alnylam.com/node/13564 <span>FDA accepts Alnylam’s siRELIS TM enzymatic ligation manufacturing platform into its Emerging Technology Program, fast-tracking global regulatory engagement</span> <span><span lang="" about="/user/220" typeof="schema:Person" property="schema:name" datatype="">hmotawe</span></span> <span>Wed, 12/17/2025 - 20:29</span> <div class="field field--name-field-year field--type-string field--label-hidden field--item">2025</div> <div class="field field--name-field-timeline-color field--type-string field--label-hidden field--item">#fff</div> <div class="field field--name-field-timeline-description field--type-text-long field--label-hidden field--item"><p>FDA accepts Alnylam’s siRELIS^TM enzymatic ligation manufacturing platform into its Emerging Technology Program, fast-tracking global regulatory engagement</p> </div> <div class="field field--name-field-list-integer field--type-integer field--label-hidden field--item">4</div> <div class="field field--name-field-link field--type-string field--label-hidden field--item">https://investors.alnylam.com/press-release?id=29466</div> <div class="field field--name-field-in-manufacturing field--type-boolean field--label-hidden field--item">Off</div> Wed, 17 Dec 2025 20:29:39 +0000 hmotawe 13564 at https://www.alnylam.com https://www.alnylam.com/node/13131 <span>Silence Disease Netherlands</span> <span><span lang="" about="/user/219" typeof="schema:Person" property="schema:name" datatype="">ozaki</span></span> <span>Mon, 11/03/2025 - 16:05</span> <div class="field field--name-field-description field--type-text-long field--label-hidden field--item"><p>Wanneer RNAi-therapieën de genen die ziekte veroorzaken uitschakelen, <strong>kunnen de beste momenten van het leven worden versterkt</strong>.</p> </div> <div class="field field--name-field-image field--type-image field--label-hidden field--item"> <img src="/sites/default/files/2025-11/alnylam-grandpa-pushing-grandson-desktop.png" width="4052" height="1447" alt="" loading="lazy" typeof="foaf:Image" class="img-responsive" /> </div> <div class="field field--name-field-main-title field--type-string field--label-hidden field--item">Silence disease</div> <div class="field field--name-field-background-mobile-image field--type-image field--label-hidden field--item"> <img src="/sites/default/files/2025-11/alnylam-grandpa-pushing-grandson-mobile.png" width="750" height="1185" alt="" loading="lazy" typeof="foaf:Image" class="img-responsive" /> </div> <div class="field field--name-field-set-weight field--type-list-integer field--label-hidden field--item">1</div> <div class="field field--name-field-title-2 field--type-text field--label-hidden field--item">Amplify life^TM</div> <div class="field field--name-field-slide-language field--type-list-string field--label-above"> <div class="field--label">Slide Language</div> <div class="field--item">NL</div> </div> Mon, 03 Nov 2025 16:05:03 +0000 ozaki 13131 at https://www.alnylam.com https://www.alnylam.com/node/12810 <span>Leqvio® (inclisiran) approved in the EU – first approved RNAi therapeutic in a prevalent disease (licensed to Novartis)</span> <span><span lang="" about="/user/220" typeof="schema:Person" property="schema:name" datatype="">hmotawe</span></span> <span>Wed, 10/01/2025 - 19:29</span> <div class="field field--name-field-year field--type-string field--label-hidden field--item">2020</div> <div class="field field--name-field-timeline-color field--type-string field--label-hidden field--item">#fff</div> <div class="field field--name-field-timeline-description field--type-text-long field--label-hidden field--item"><p>Leqvio® (inclisiran) approved in the EU – first approved RNAi therapeutic in a prevalent disease (licensed to Novartis)</p> </div> <div class="field field--name-field-list-integer field--type-integer field--label-hidden field--item">1</div> <div class="field field--name-field-in-manufacturing field--type-boolean field--label-hidden field--item">Off</div> Wed, 01 Oct 2025 19:29:20 +0000 hmotawe 12810 at https://www.alnylam.com https://www.alnylam.com/node/12809 <span>Positive Topline Results from HELIOS-A Phase 3 Study of Vutrisrian in Patients with hATTR PN</span> <span><span lang="" about="/user/220" typeof="schema:Person" property="schema:name" datatype="">hmotawe</span></span> <span>Wed, 10/01/2025 - 18:43</span> <div class="field field--name-field-year field--type-string field--label-hidden field--item">2021</div> <div class="field field--name-field-timeline-color field--type-string field--label-hidden field--item">#fff</div> <div class="field field--name-field-timeline-description field--type-text-long field--label-hidden field--item"><p>Positive Topline Results from HELIOS-A Phase 3 Study of Vutrisrian in Patients with hATTR PN</p> </div> <div class="field field--name-field-list-integer field--type-integer field--label-hidden field--item">1</div> <div class="field field--name-field-link field--type-string field--label-hidden field--item">https://investors.alnylam.com/press-release?id=25366</div> <div class="field field--name-field-in-manufacturing field--type-boolean field--label-hidden field--item">Off</div> Wed, 01 Oct 2025 18:43:01 +0000 hmotawe 12809 at https://www.alnylam.com https://www.alnylam.com/node/12808 <span>Leqvio® (inclisiran) approved in the US (licensed to Novartis)</span> <span><span lang="" about="/user/220" typeof="schema:Person" property="schema:name" datatype="">hmotawe</span></span> <span>Wed, 10/01/2025 - 18:16</span> <div class="field field--name-field-year field--type-string field--label-hidden field--item">2021</div> <div class="field field--name-field-timeline-color field--type-string field--label-hidden field--item">#fff</div> <div class="field field--name-field-timeline-description field--type-text-long field--label-hidden field--item"><p>Leqvio® (inclisiran) approved in the US (licensed to Novartis)</p> </div> <div class="field field--name-field-list-integer field--type-integer field--label-hidden field--item">3</div> <div class="field field--name-field-link field--type-string field--label-hidden field--item">https://investors.alnylam.com/press-release?id=26301</div> <div class="field field--name-field-in-manufacturing field--type-boolean field--label-hidden field--item">Off</div> Wed, 01 Oct 2025 18:16:35 +0000 hmotawe 12808 at https://www.alnylam.com https://www.alnylam.com/node/12807 <span>Positive Topline Results from the ATLAS Phase 3 Study of fitusiran (licensed to Sanofi)</span> <span><span lang="" about="/user/220" typeof="schema:Person" property="schema:name" datatype="">hmotawe</span></span> <span>Wed, 10/01/2025 - 18:15</span> <div class="field field--name-field-year field--type-string field--label-hidden field--item">2021</div> <div class="field field--name-field-timeline-color field--type-string field--label-hidden field--item">#fff</div> <div class="field field--name-field-timeline-description field--type-text-long field--label-hidden field--item"><p>Positive Topline Results from the ATLAS Phase 3 Study of fitusiran (licensed to Sanofi)</p> </div> <div class="field field--name-field-list-integer field--type-integer field--label-hidden field--item">4</div> <div class="field field--name-field-in-manufacturing field--type-boolean field--label-hidden field--item">Off</div> Wed, 01 Oct 2025 18:15:25 +0000 hmotawe 12807 at https://www.alnylam.com https://www.alnylam.com/node/12796 <span>First POC for the first commercial use of a new enzymatic-ligation-based oligonucleotide manufacturing platform, advancing how siRNA-based medicines are made</span> <span><span lang="" about="/user/220" typeof="schema:Person" property="schema:name" datatype="">hmotawe</span></span> <span>Wed, 10/01/2025 - 16:39</span> <div class="field field--name-field-year field--type-string field--label-hidden field--item">2024</div> <div class="field field--name-field-timeline-color field--type-string field--label-hidden field--item">#fff</div> <div class="field field--name-field-timeline-description field--type-text-long field--label-hidden field--item"><p>First POC for the first commercial use of a new enzymatic-ligation-based oligonucleotide manufacturing platform, advancing how siRNA-based medicines are made</p> </div> <div class="field field--name-field-list-integer field--type-integer field--label-hidden field--item">1</div> <div class="field field--name-field-in-manufacturing field--type-boolean field--label-hidden field--item">On</div> Wed, 01 Oct 2025 16:39:25 +0000 hmotawe 12796 at https://www.alnylam.com